Clinical experience and safety using phosphatidylcholine injections for the localized reduction of subcutaneous fat: a multicentre, retrospective UK study
This 2006 multicentre retrospective study evaluated the safety and patient satisfaction associated with subcutaneous phosphatidylcholine injections for localized fat reduction. Thirty-nine trained UK physicians reported outcomes from 10,581 treatments over an average of 13.1 months. Local adverse effects such as swelling, erythema, and tenderness were mostly rated as mild or